Sonoclot analysis in healthy children

Evan G. Pivalizza, Penelope J. Pivalizza, Spencer Kee, Lewis I. Gottschalk, Peter Szmuk, David C. Abramson

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Although use of the Sonoclot device (Sienco, Inc., Morrison, CO) has been reported in isolated pediatric cases and in small reports in neonates, there are no published data for normal pediatric patients. As the device is used in situations of abnormal coagulation, such as cardiac and liver transplantation surgery, our aim was to determine normal data ranges in healthy pediatric surgical patients. Blood was withdrawn after anesthetic induction, and the Sonoclot activated clotting time, rate of clot formation, time to peak amplitude, and peak amplitude was compared among four pediatric groups (< 12 mo, 13-24 mo, 25-48 mo, 49 mo-9 yr) and an adult group. The Sonoclot activated clotting time in the < 12-mo and the Adult groups were shorter than the oldest group of children (P < 0.05), although all were within the anticipated normal range, and there were no significant differences in clot rate, peak amplitude, and time to peak amplitude among groups without apparent trends with increasing age. These Sonoclot variables quantify adequate global clot formation in pediatric patients and will facilitate clinical coagulation management with appropriate pediatric normal ranges, avoiding the application of extrapolated adult data to children.

Original languageEnglish (US)
Pages (from-to)904-906
Number of pages3
JournalAnesthesia and analgesia
Issue number4
StatePublished - 2001

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Sonoclot analysis in healthy children'. Together they form a unique fingerprint.

Cite this